Daily Stock Analysis, ANIP, ANI Pharmaceuticals Inc, priceseries

ANI Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
47.76
Close
47.68
High
48.95
Low
47.51
Previous Close
47.89
Daily Price Gain
-0.21
YTD High
65.81
YTD High Date
Feb 16, 2017
YTD Low
43.71
YTD Low Date
Mar 21, 2017
YTD Price Change
-13.59
YTD Gain
-22.18%
52 Week High
70.92
52 Week High Date
Aug 15, 2016
52 Week Low
43.71
52 Week Low Date
Mar 21, 2017
52 Week Price Change
-1.52
52 Week Gain
-3.09%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 9. 2015
59.28
Mar 3. 2015
65.50
15 Trading Days
10.49%
Link
LONG
Jul 10. 2015
62.22
Jul 24. 2015
68.27
10 Trading Days
9.72%
Link
LONG
Feb 19. 2016
30.44
Mar 10. 2016
33.67
14 Trading Days
10.60%
Link
LONG
Mar 31. 2016
33.66
Apr 29. 2016
45.39
21 Trading Days
34.84%
Link
LONG
May 24. 2016
50.09
Jun 9. 2016
54.16
11 Trading Days
8.12%
Link
LONG
Jul 18. 2016
56.01
Aug 19. 2016
68.19
24 Trading Days
21.75%
Link
Company Information
Stock Symbol
ANIP
Exchange
NasdaqGM
Company URL
www.anipharmaceuticals.com
Company Phone
2186343500
CEO
Arthur S. Przybyl
Headquarters
Minnesota
Business Address
210 MAIN STREET WEST, BAUDETTE, MN 56623
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001023024
About

ANI Pharmaceuticals, Inc. is a pharmaceutical company, which develops, manufactures and markets branded and generic prescription pharmaceuticals. The company's areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. It has two pharmaceutical manufacturing facilities located in Baudette, Minnesota, which produces oral solid dose products, as well as liquids and topicals, narcotics, and potent products. ANI Pharmaceuticals was founded on August 29, 1996 and is headquartered in Baudette, MN.

Description

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States. It focuses on producing controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. The company offers Erythromycin Ethylsuccinate to treat infections; Esterified Estrogen with Methyltestosterone for treating vasomotor symptoms of menopause; Etodolac to treat pain caused by osteoarthritis, rheumatoid arthritis, and other conditions; Fenofibrate for treating hypercholesterolemia; Flecainide to treat arrhythmia; Fluvoxamine for treating obsessive-compulsive and social anxiety disorders; and Hydrocortisone Enema and Cortenema to treat ulcerative colitis. It also provides Hydrocortisone Rectal Cream to treat inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses; Lithium Carbonate ER and Lithobid for bipolar disorder; Mesalamine Enema to treat distal ulcerative colitis, proctosigmoiditis, or proctitis; Methazolamide to treat ocular conditions; and Metoclopramide and Reglan to treat gastroesophageal reflux. In addition, the company offers Nilutamide to treat metastatic prostate cancer; Nimodipine that reduces the ischemic deficits in patients with subarachnoid hemorrhage; Opium Tincture to treat diarrhea; Oxycodone capsules and oral solution for pain; Propafenone to treat arrhythmia; Propranolol ER and Inderal LA for managing hypertension in patients with angina pectoris; and Vancomycin and Vancocin for use in treating C. difficile-associated diarrhea and enterocolitis. Further, it provides contract manufacturing services for other pharmaceutical companies. The company markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. is headquartered in Baudette, Minnesota.